Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Antispasmodic and Anticholinergic H2 Blocking Agents Market: By Drug Type: Natural, Semisynthetic Derivatives, Synthetic Compounds; By Indication; By Mode of Administration; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2018-2028); Competitive Landscape; Industry Events and Developments
Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Outlook
The global antispasmodic and anticholinergic H2 blocking agents market is being driven by the rising anticholinergic drugs market. The anticholinergic drugs market is expected to grow at a CAGR of 4% in the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be a Significant Regional Market for the Antispasmodic and Anticholinergic H2 Blocking Agents Industry
North America is a significant region in the global market for antispasmodic and anticholinergic H2 blocking agents, and the region is expected to remain a major market in the coming years as well. The growth in the region is primarily being driven by the growing medical sector. Europe and the Asia Pacific are also expected to emerge as major markets for antispasmodic and anticholinergic H2 blocking agents. The rapidly developing medical infrastructure and diagnostic facilities in emerging economies, such as China and India, and favourable care reimbursement policies are anticipated to boost the growth of the global demand for antispasmodic and anticholinergic H2 blocking agents.
Antispasmodic and Anticholinergic H2 Blocking Agents: Market Segmentation
Antispasmodics and anticholinergics are a category of medicines, such as natural belladonna alkaloids, including belladonna, atropine, scopolamine, hyoscyamine, and other medications. Antispasmodics and anticholinergics are commonly used to alleviate cramps and spasms of the intestines, stomach, and bladder. These medications are used in conjunction with antacids and other medicines to treat ulcers, vomiting, nausea, and motion sickness. Antispasmodics and anticholinergic medications are also useful in the treatment of poisoning caused by various medicines, mushrooms, and organic pesticides.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on drug type, the industry can be divided into the following:
- Natural
- Semisynthetic Derivatives
- Synthetic Compounds
On the basis of indication, the market can be segmented as follows:
- Intestinal and Renal Colic Cramps
- Diarrhoea
- Spastic Constipation
- Gastritis
- Dysmenorrhea
- Others
On the basis of mode of administration, the market can be divided as follows:
- Oral
- Parenteral
- Topical
- Others
The distribution channels can be categorised as follows:
- Hospitals
- Retail Pharmacies
- Online
- Others
The regional markets for antispasmodic and anticholinergic H2 blocking agents can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Healthcare Sector Bolstering the Market Growth Antispasmodic and Anticholinergic H2 Blocking Agents
The growing availability of advanced diagnostic and treatment facilities for diseases including intestinal and renal colic cramps, diarrhoea, spastic constipation, gastritis, and dysmenorrhoea is a key factor that is expected to fuel the growth of the global market for antispasmodic and anticholinergic H2-blockers. Developing medical infrastructure and diagnostic facilities in emerging markets, such as China and India, and favourable care reimbursement policies are expected to strengthen the growth of the global demand for antispasmodic and anticholinergic H2 blocking agents. The rising research and development activities to introduce new and combined treatment technologies and update existing ones are also expected to drive the global demand for antispasmodic and anticholinergic H2 blocking agents in the forecast period.
Key Industry Players in the Global Antispasmodic and Anticholinergic H2 Blocking Agents Market
The report gives a detailed analysis of the following key players in the global antispasmodic and anticholinergic H2 blocking agents market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Sun Pharmaceutical Industries Ltd.
- IriSys, LLC
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Type, Indication, Mode of Administration, Distribution Channel, Region |
| Breakup by Drug Type | Natural, Semisynthetic Derivatives, Synthetic Compounds |
| Breakup by Indication | Intestinal and Renal Colic Cramps, Diarrhoea, Spastic Constipation, Gastritis, Dysmenorrhea, Others |
| Breakup by Mode of Administration | Oral, Parenteral, Topical, Others |
| Breakup by Distribution Channel | Hospitals, Retail Pharmacies, Online, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Sun Pharmaceutical Industries Ltd., IriSys, LLC, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Analysis
8.1 Key Industry Highlights
8.2 Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market (2018-2022)
8.3 Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast (2023-2028)
8.4 Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Drug Type
8.4.1 Natural
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Semisynthetic Derivatives
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Synthetic Compounds
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.5 Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Indication
8.5.1 Intestinal and Renal Colic Cramps
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Diarrhoea
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Spastic Constipation
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Gastritis
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Dysmenorrhea
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
8.5.6 Others
8.6 Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Mode of Administration
8.6.1 Oral
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Parenteral
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Topical
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Others
8.7 Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Distribution Channel
8.7.1 Hospitals
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Retail Pharmacies
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Online
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Others
8.8 Global Antispasmodic and Anticholinergic H2 Blocking Agents Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles (*This list is only indicative. The report contains a more comprehensive list of players.)
12.2.1 Sun Pharmaceutical Industries Ltd.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 IriSys, LLC
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Antispasmodic and Anticholinergic H2 Blocking Agents Market: Key Industry Highlights, 2018 and 2028
2. Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Drug Type (USD Million), 2018-2022
3. Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Drug Type (USD Million), 2023-2028
4. Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Indication (USD Million), 2018-2022
5. Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Indication (USD Million), 2023-2028
6. Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Mode of Administration (USD Million), 2018-2022
7. Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Mode of Administration (USD Million), 2023-2028
8. Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Distribution Channel (USD Million), 2018-2022
9. Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Distribution Channel (USD Million), 2023-2028
10. Global Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Region (USD Million), 2018-2022
11. Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Region (USD Million), 2023-2028
12. North America Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2018-2022
13. North America Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Europe Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2018-2022
15. Europe Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Asia Pacific Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2018-2022
17. Asia Pacific Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Latin America Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2018-2022
19. Latin America Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Middle East and Africa Antispasmodic and Anticholinergic H2 Blocking Agents Historical Market: Breakup by Country (USD Million), 2018-2022
21. Middle East and Africa Antispasmodic and Anticholinergic H2 Blocking Agents Market Forecast: Breakup by Country (USD Million), 2023-2028
22. Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Structure
Key Questions Answered in the Report
The global antispasmodic and anticholinergic H2 blocking agents market is being aided by the anticholinergic drugs market, which is expected to grow at a CAGR of 4% between 2021 and 2026.
The growth of the industry is being driven by factors like the rising population, increased disposable incomes, rising health disorders, increasing availability of advanced diagnostic and treatment facilities, and the rising technological advancements.
The rising research and technological advancements are an important industry trend guiding the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading drug types in the market are natural, semisynthetic derivatives, and synthetic compounds.
The major indications segments in the industry are intestinal and renal colic cramps, diarrhoea, spastic constipation, gastritis, and dysmenorrhea, among others.
The significant modes of administration in the market are oral, parenteral, and topical, among others.
The major distribution channels in the industry are hospitals, retail pharmacies, and online, among others.
The major players in the industry are Sun Pharmaceutical Industries Ltd. and IriSys, LLC, among others.
Analyst Review
The global antispasmodic and anticholinergic H2 blocking agents market is being driven by the growing availability of advanced diagnostic and treatment facilities and the rising anticholinergic drugs market. Aided by the rising R&D activities, the anticholinergic drugs market is expected to witness a moderate growth in the forecast period of 2023-2028, growing at a CAGR of 4%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By drug type, the market is segmented into natural, semisynthetic derivatives, and synthetic compounds. Based on indication, the industry is divided into intestinal and renal colic cramps, diarrhoea, spastic constipation, gastritis, and dysmenorrhea, among others. On the basis of mode of administration, the industry is categorised into oral, parenteral, and topical, among others. By distribution channel, the market is segmented into hospitals, retail pharmacies, and online, among others. The major regional markets for antispasmodic and anticholinergic H2 blocking agents are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sun Pharmaceutical Industries Ltd. and IriSys, LLC, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER